Moderna's New Vaccine Boosts Shares 1.33%!
StockSavvyWednesday, Jun 4, 2025 6:08 am ET
1min readModerna, Inc. rose 1.33% in premarket trading. The company introduced mNEXSPIKE, a new COVID-19 vaccine, which could potentially reduce the burden of disease from COVID-19. Additionally, Moderna's pipeline programs, including Phase 3 readouts and potential product launches, are anticipated to reach upcoming milestones.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
Comments
No comments yet